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ABSTRACT:
Introduction:  Access to essential medicines is a human right
and an objective of the National Medicines Policy in Australia.
Health workforce distribution characteristics in remote Australia
implies registered nurses (RNs) may find themselves responsible
for a broader range of activities in the medication management
cycle than they would be elsewhere in the nation. The regulation
of health professionals and their training requirements provides
essential but complex protections for the public. These
protections include the National Registration and Accreditation
Scheme for health practitioners and the Australian Health
Practitioner Regulation Agency. Other levels of control or
regulation are also exerted over health professionals via
mechanisms such as salaries and funding arrangements,
insurance requirements, admitting rights to healthcare facilities,
and legislation controlling the use of medicines and therapeutic
devices. This study aimed to examine national legislation and
regulations concerning the use of medications from a nursing
perspective, focusing on the context of health service delivery in
remote areas.
Methods:  Australian state and territory medicines legislation
and regulations was interrogated for answers to the questions
‘Can an RN prescribe a medication?’, ‘Can an RN dispense a
medication?’, ‘Can an RN supply or issue a medication?’ and ‘Can
an RN administer a medication?’
Results:  Inconsistencies were identified nationally in the names
and general structure of the legislation, the location of
information relating to authorised roles with regards to
medications and key terms used to describe medicines and the







elements of the medication management cycle. Administrations
of Schedule 4 and 8 medicine according to an order from an
authorised prescriber are the only nationally consistent roles
RNs are authorised to undertake with regards to medicines.
Twenty-eight variations were identified with regards to additional
authorisations for RNs.
Conclusion:  RNs make up more than half of the registered
Australian health professional workforce and are the most
consistently distributed across the nation, yet their legislated
responsibilities in relation to working with medicines are
inconsistent. Given the inconsistencies, RNs providing health
care in remote Australia may be unable to undertake aspects of
the medication management cycle that their work environment
demands in the best interest of their patients and absence of
other healthcare providers. The lack of legislative consistency
nationally for medicines in Australia is likely to impede timely
access to medications for patients. Regulatory inconsistencies
may also result in RNs working well below or beyond their legal
scope of practice, thereby creating clinical and workforce risks.
Such risks are a significant matter for remote health service
provision. Resolving these issues will require a collaborative
national approach with consideration given to how the health
workforce is distributed, current nursing responsibilities and
relevant service delivery models for remote Australia.
Keywords:
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FULL ARTICLE:
Introduction
The regulation of health professionals and their training
requirements provides essential but complex protections for the
public . In Australia, these protections include the introduction of
a National Registration and Accreditation Scheme for health
practitioners (NRAS) in 2010 and the establishment of the
Australian Health Practitioner Regulation Agency (AHPRA) .
Other levels of control or regulation are also exerted over health
professionals via mechanisms such as salaries and funding
arrangements, insurance requirements, admitting rights to
healthcare facilities, and legislation controlling the use of
medicines and therapeutic devices .
Access to essential medicines is a human right in the
International Treaty on Social, Economic and Cultural Rights . Its
importance is also evidenced in the Declaration of Alma Ata
and the Sustainable Development Goals . Australia is a signatory
to each of these instruments, and appropriate and timely access
to medicine is also a central objective of Australia’s National
Medicines Policy . Australia’s Pharmaceutical Benefits Scheme
(PBS) underpins affordable access to essential medicines. In
2016–2017, approximately 0.7% of the nation’s gross domestic
product (A$12.06 billion) was spent on medicines subsidised
through the PBS , reflecting their critical, varied role.
In Australia, when episodes of health care involve the use of
medicines it is acknowledged that the Medication Management
Cycle (MMC) will occur . The MMC has been described as
consisting of nine steps :
1.  deciding to prescribe a medicine
2.  recording the medication order or prescription
3.  reviewing the medication order/prescription
4.  issuing the medicines, which includes manufacturing and
dispensing or supplying the medicine
5.  providing medicines information to the consumer and those
involved in storing and administering the medicine
6.  appropriately distributing and storing the medicine
7.  administering the medicine
8.  monitoring the consumers’ response to the medicine
9.  communicating or transferring verified information regarding
medicines use and treatment plans.
 While many healthcare professionals may be involved in
different phases of the MMC, in Australia, medical practitioners
and pharmacists are generally acknowledged as responsible for
the first six. Nevertheless, because medications play such a vital
role in health care and because other professionals, including
nurses, are also expected to play at least some role in the MMC,
instruments that provide a means of effecting control and
coordination of use must have demonstrable relevance.
Among such instruments, legislation is key to clarifying where,
by whom and how acts of prescribing, dispensing, supplying and
administering medications should occur. Within Australia’s busy,
federated legislative landscape, there are many opportunities for
incongruence between instruments that pertain to medicines.
Although this has been identified as a risk to patients and health
professionals , little has been published about the issue with
regard to registered nurses (RNs) and no complete analysis has
been undertaken from a nursing perspective since the
introduction of the NRAS and AHPRA in 2010 and subsequent
changes to medicines legislation .
This is a significant gap because RNs and RN/midwives are the
mainstay of the Australian health professional workforce,
comprising more than half of its total (53.6% in 2017) and are
the most evenly distributed across the nation
(Fig1). Moreover, in the remote and very remote areas that
constitute most of Australia’s land mass and where community
health and wellbeing are generally poorest , the role of RNs is
especially significant, with many communities reliant on nurse-
led services . In these parts of the nation, RNs have
historically been and continue to be the mainstay and therefore
tend to carry more responsibility for healthcare delivery,
including the MMC .
The nurse practitioner (NP) role has been recognised in Australia
since 2000. In Australia, NPs are RNs who have completed
postgraduate training at a masters level and have applied for and
hold the specific NMBA Nurse Practitioner endorsement. NPs
are authorised prescribers within their individual speciality areas
and are able to apply for Pharmaceutical Benefits Scheme (PBS)
prescribing rights . Despite initial hopes that NPs would fill the
medical practitioner void in remote Australia, Figure 1 highlights



















2017 health workforce figures an additional 481 NPs would be
required in very remote Australia to bring the combined medical
practitioner-to-NP ratio in line with that of major cities .
The extended role of nurses in medication management in
remote Australia has been acknowledged from the earliest days
of the PBS . In 1999, amendments made to the National Health
Act 1953 effectively established the Remote Area Aboriginal
Health Service program, enabling the free supply of PBS
medications without a prescription at designated facilities in
remote areas . This removed a barrier to accessing affordable
medicines due to a lack of local medical practitioners for
obtaining prescriptions and pharmacies for the dispensing of
medications. Despite this, it is unclear if nurses in these areas,
whose roles have in common some elements of work usually
undertaken by general practitioners or pharmacists  and may
therefore include supplying and/or initiating medications, are
also supported to do this by state or territory legislation
governing the practices of health practitioners with regards to
medicines.
Despite the significance of these advanced practice roles for
RNs and the crucial position they therefore hold in the quality
use of medicines there has, been little research outside of
Queensland into RNs and the MMC in remote Australia or the
legislative and practice frameworks that might best support
quality use of medicines by nurses in remote Australia.
The objective of this study was to examine medicines and
poisons legislation nationally from a nursing perspective, with a
focus on the context of health service delivery in remote areas of
Australia.
Figure 1:  2017 health professional by type per 1000 estimated resident population and Australian Statistical Geography
Standard – Remoteness Area 2016.
Methods
In August 2017, state and territory medicines legislation and
regulations for all Australian states and territories that have
areas classed as ‘very remote’ according to the Australian
Statistical Geography Standard – Remoteness Area 2016 (ASGS-
RA 2016)  were interrogated for answers to the questions ‘Can
an RN prescribe a medication?’, ‘Can an RN dispense a
medication?’, ‘Can an RN supply or issue a medication?’ and ‘Can
an RN administer a medication?’ in regards to RNs who do not
hold NP endorsement. The legislation was again reviewed in
2019 for changes and amendments; at this time Victoria and the
Australian Capital Territory were included in analysis for National
completeness (Supplementary table 1). The medicines and
poisons, or similarly titled Act and Regulations for each state and
territory, will hereafter be referred to by abbreviated state or
territory name and ‘Act’ or ‘Regulation’.
Findings will be presented as descriptions of the relevant
definitions, authorisations and sections of legislation accessed in
order to answer the identified questions for Schedule 2, 3, 4 and
8 medicines. Tables will be used where possible to summarise
findings.
Supplementary table 1:  Overview of Australian state and
territory medicines legislation and regulations
Ethics approval
Ethics approval was granted from the Edith Cowan University
Human Research Ethics Committee (Approval 19386).
Results
Instrument and format
The title of legal instruments and location of legislative details
regarding authorisations for RNs regarding medicines varies
across Australian states and territories. In South Australia (SA),
the Northern Territory (NT) and New South Wales (NSW) most
of these details are contained within the relevant Act. In
Queensland, the Australian Capital Territory (ACT), Victoria,
Tasmania and Western Australia (WA), the details are
predominantly located within Regulations.







such as gazetting or the issuing of individual authorisations or
licences are enabled in legislation and utilised variably across
the nation.
Scheduling of medicines
All Australian states and territories are party to a federal
legislative instrument, the Poisons Standard (2019), also known
as the Standard for the Uniform Scheduling of Medicines and
Poisons (SUSMP). The terminology used to describe and refer to
the different schedules of medicine within both state and
territory legislation differs from the SUSMP (Table 1).
Table 1:  Standard for the Uniform Scheduling of Medicines and Poisons definition and terminology used to describe
medicine schedules in Australian legislation
Endorsements, training, authorities and protocols
A variety of mechanisms across Australia make provisions for
RNs to work more broadly through the MMC. The National
Health Practitioner Law Act 2010, as enacted by each state and
territory and enabling the powers and responsibilities of NRAS
and AHPRA, makes provision for suitably qualified, registered
health professionals to apply for an endorsement in a certain
area of practice . RNs who have undertaken approved training
can apply to the Nursing and Midwifery Board of Australia
(NMBA) for an endorsement for scheduled medicines for RNs
(rural and isolated practice) (Registration Standard for
Endorsement of Registered Nurses (Rural and Isolated Practice)
–RIPEN) . This endorsement is recognised in legislation in all
states and territories with the exception of WA and Tasmania .
However, Queensland and Victoria are the only states in which
RIPEN is actually needed for an RN to undertake broader
aspects of medication management practice. The NMBA is
preparing to discontinue RIPEN .
In NSW, a letter of appointment may allow RNs to supply and/or
initiate listed medications according to Standing Orders for the
Supply or Administration of Medications under the Nurse
Designated Emergency Care (NDEC) model and related
Guidelines and Medication Standing Orders . This entails
training and certification that is only available and recognised in
a limited number of NSW rural and remote facilities. In WA, RNs
providing sexual health services are required to undertake
additional training to be able to initiate medications according to
specific protocols. There is no requirement in WA for RNs in
remote nursing roles to undertake additional education prior to
initiating and supplying medications according to remote area
nursing protocols . Similarly, in SA, the NT, ACT and Tasmania,
there are no requirements for RNs to have undertaken additional
education to supply medications according to a protocol. 
Definitions and the terminology describing protocols and
standing orders also vary across the country, and different
protocols are authorised through state or territory legislation to
allow RNs to undertake extended MMC roles. Both Queensland
and Victoria utilise the Primary Clinical Care Manuals (PCCM) for
most nurse-managed care for acute presentations in remote
contexts. In the NT and at multiple remote health sites in SA
the Remote Primary Healthcare Manual (RPHCM) suite has been
adopted. The NDEC Nursing Management Guidelines (NDEC
NMG) and Medication Standing Orders are utilised at limited
sites in NSW . The PCCM, RPHCM and NDEC NMG provide










presentations and protocols for the use of specific drugs. South
Australian and Tasmanian legislative mechanisms do not
stipulate the use of specific manuals or protocols. WA utilises a
system of Structured Administration and Supply Arrangements
(SASAs) to authorise administration and supply of medications
by RNs in certain contexts. A variety of SASAs are issued by the
state, and mechanisms exist for health organisations or
individual medical practitioners to develop their own SASAs for
use by RNs . Unlike the RPHCM, PCCM and NDEC NMG, SASAs
only relate to a specific medication, its indication for use and
dose. SASAs do not provide guidance for RNs around patient
assessment, differential diagnoses or clinical decision-making
guidance in respect to the condition being treated.
Endorsements and training requirements relating to RNs who are
immunisation providers were not included in this analysis due to
their multitude and complexity.
Prescribe, prescriber, prescription
Prescribing traditionally relates to stages 1–3 of the MMC.
Definition:  Definitions of terms, where provided, are in the Act
for WA, the NT and Queensland. SA defines only prescriber in
the Regulations. The ACT defines prescribe and prescription in
the Act and prescriber in the Regulations. No clear definitions
are provided by NSW or Tasmania. Victoria defines prescription
by listing two provisions of what a prescription is not within the
Regulations (Table 2).
Authorised actions for RNs: RNs without an NP’s endorsement
are not authorised to prescribe medications in any practice
context. However, under the new Queensland Medicines and
Poisons Act 2019, there are provisions for individuals to apply for
a prescribing approval, and this could include RNs.
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Table 2:  Definitions and authorised actions for prescribe and dispense
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Dispense
The dispensing of medications traditionally involves stages 4–6
of the MMC.
Definition:  The ACT defines dispense in the Act, and SA and
WA within the Regulations similarly as being to supply a drug
according to a prescription. Queensland also defines the term
within its Regulations but specifies that dispensing is to sell a
drug in accordance with a prescription. The NT makes no
reference to the term. Victoria does not define the term. NSW
and Tasmania do not define the term but in these states supply
includes the act of dispensing, with Tasmania specifying that
dispensing occurs in accordance with a prescription (Table 3).
Authorised actions for RNs:  SA only mentions pharmacists and
medical practitioners in the more than 12 provisions for actions
that must be undertaken when dispensing. RNs in WA and
Queensland are not authorised to dispense. Dispensing is not a
specific action regulated in the NT. Pharmacists are the only
health professionals authorised to dispense in NSW. The
situation in Tasmania is unclear because person is undefined
when referring to the dispensing of narcotic substances and
RNs’ status related to dispensing is not clarified. Dispense is not
defined by Victoria; however, authorised (RIPEN) RNs may sell
Schedule 3, 4 and 8 medications to patients under their care if
there is a therapeutic need; there is no stipulation that a
prescription is required.
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Table 3:  Definitions and authorised actions for supply
8 of 13
Supply
The supply of medications may relate only to stages 4–6 of the
MMC. However, where supply is authorised without a
prescription, stages 1–3 of the MMC will also be occurring. For
example, where an RN is authorised to supply any medication
without an order from a prescriber, the RN is then required to
assess and use clinical reasoning to determine the need for
medication; make a decision about appropriate medication use
either independently or according to a protocol; record
information about the medication route, dose and timing; and
the supply and/or administration of the medication to the
patient.
Definition:  Although the Acts in SA, WA, NT, Queensland, NSW,
ACT, Victoria and Tasmania all define supply, the definitions are
different. Acts in WA, Queensland and the ACT specifically
mention that supply does not include administer, whereas in
Tasmania the term supply includes administer.
Authorised actions for RNs: Table 3 summarises differences in
authorised actions for RNs in relation to the supply of medicines.
Twenty-one variable provisions relating to supply authorisations
were identified.
Schedule 2 and 3 medications  There is no national
consistency relating to the supply of Schedule 2 or
3 medications by RNs (Table 3).
Schedule 4 medications  There is no national consistency
relating to the supply of Schedule 4 medications by RNs
(Table 3).
Schedule 8 medications  There is no national consistency
relating to the supply of Schedule 8 medications by RNs
(Table 3).
Administer
Traditionally administering a medication is stage 8 of the MMC.
However, similar to the situation with supply of medications,
where administration is authorised without an order from an
authorised prescriber then steps 1–6 of the MMC may also be
occurring.
Definition:  Administer is a frequently used term in legislation. It
is not defined in the Acts or Regulations of SA, WA, NSW, ACT,
Victoria or Tasmania (Table 4).
Authorised actions for RNs: Significant variations exist
regarding administration authorisations for RNs across Australian
states and territories, summarised in Table 4. Due to their
complexity and multitude, provisions regarding RNs and the
administration of Schedule 4 medicines that are also vaccines
have been excluded from this analysis. All findings regarding
authorised actions in Queensland relate to authorisations made
under the Health (Drugs and Poisons) Regulation 1996 which
remains in effect until the new Medicines and Poisons
(Medicines) Regulations 2019 have been finalised and enacted.
Schedule 2 and 3 medications  There is no national
consistency relating to the administration of Schedule 2 or
3 medications by RNs (Table 4).
Schedule 4 medications  Nationally, RNs are consistently
authorised to administer a Schedule 4 medication on the order
of an authorised prescriber. Several variations exist nationally in
additional authorisations for RNs relating the administration of
Schedule 4 medicines (Table 4).
Schedule 8 medications  Nationally, RNs are consistently
authorised to administer a Schedule 8 medication on the order
of an authorised prescriber. Several variations exist nationally in
additional authorisations for RNs relating the administration of
Schedule 8 medicines (Table 4).
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Table 4:  Definitions and authorised actions for administer
Discussion
Nationally inconsistent medicines and poisons legislation and
related legal instruments affect the capacity for RNs in Australia
to understand and therefore practise confidently within their
legal scope. With the burgeoning demand for healthcare
services, changing models of health service delivery, and new
and emerging health issues, it is vital that systems regulating
health professional practice adapt quickly.
Features of the Australian legal system and the processes
involved in effecting change to Acts and Regulations hamper the
ease with which adaptations can be made to accommodate
changing healthcare delivery needs, such as in the management
of a public health outbreak or health professional staffing crisis.
The format and content of legislation pertaining to the use of
medicines also vary considerably. Authorised actions for health
professionals are difficult to locate, collate and interpret where
they are not presented by profession, authorised action and the
schedule of medicine, or where summary tables of authorised
actions by profession are not provided.
Inconsistent definitions in the legislation also affect the ease
with which legislation can be interpreted. Queensland is the only
jurisdiction that defines all key terms. Nationally, terms such as
supply are used inconsistently or used in some contexts but not
others. Moreover, the use of several terms to describe a single
schedule of medicine both within and across jurisdictions makes
interpretation more complex and confusing.
The 28 identified variants in how RNs are authorised to work
with medicines seems an unnecessary burden on nurses who
need to be able to work consistently across Australia. The
greatest impact of these inconsistencies is likely to be in remote
areas, where RNs have responsibility for more of the MMC than
their urban counterparts. Where RNs are authorised to
undertake extended practice with regards to medications, such
as supplying medications according to authorised protocols,
differences in required training and preparation are significant
and these impact on workforce mobility and quality of care.
These are important policy issues in a context of greater equity
of access to health care and medications for people living in
remote Australia. A lack of consistency in legislation relating to
how RNs work with medications in Australia is a hidden, systemic
cause of inequity impacting on nursing practice and directly
affecting the health of those who live in remote parts of the
nation. By far the greatest proportion of the people affected are
Aboriginal and Torres Strait Islanders. Eliminating this hidden,
systemic inequity will, therefore, contribute to closing the gap in
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life expectancy between Aboriginal and Torres Strait Islander
and non-Indigenous Australians. Harmonisation of nursing
practice in relation to all aspects of the medication management
cycle via nationally consistent medicines legislation will improve
equity of access to health care and medications. This will
enhance the quality of care provided to those Australians whose
health is generally poorest. However, this demands of decision
makers a nationally collaborative approach and a willingness for
policy and legislative reform efforts. An appetite and ambition for
such reform has been characteristic in some areas of Australian
health care, so it is really now just a question of the desire of
decision-makers to act on this practical issue that will lead to
improvements in health outcomes in remote Australia.
Limitations
This analysis has neither explored nor compared the legislative
provisions relating to RNs and the possession of scheduled
substances, nor the multitude of legislative requirements that
exist for storing, labelling and destroying medicines. Also not
explored are the requirements and provisions related to RNs and
the administration of vaccines. The differing requirements of the
state and territories regarding verbal orders from authorised
prescribers have similarly not been explored. Although
warranted, analysis of authorisations for both RNs who hold NP
endorsement and authorisations for Aboriginal health workers
and practitioners was not possible within the scope of this
project.
Conclusion
Administrations of Schedule 4 and 8 medications according to
an order from an authorised prescriber are the only actions
authorised consistently for RNs across Australia. Other actions
relevant to a specific schedule supported in one state or
territory are not necessarily supported in others, and the
regulated educational requirements for extended roles with
medicines differ. This lack of consistency poses a significant risk
to not only RNs working in remote areas but all RNs whose roles
with medications exceed these two defined actions. A lack of
uniformity between Australia’s medicines and poisons legislation
means RN practice will vary across Australia and patients may
not receive a standard or universal level of care.
It is imperative to acknowledge that in Australia a health
professional’s individual scope of practice is defined jointly by
legislation; their level of educational preparation, knowledge,
skills and experience; the needs of the community; and the
policies and procedures of their employing organisation. Any or
all of these elements may be either broader or more limited than
legislated roles with medicines. With Australia’s highly mobile
workforce and high turnover rates in remote areas ,
inconsistencies in legislated authorisations regarding medicines
may result in RNs working either suboptimally or outside their
legal scope.
Little has been published about the effects of legislative
requirements on nursing practice and health service delivery in
remote Australia, where health status is generally poorer and
where access to health services and health professionals is more
limited than in other parts of the country . Additionally,
although RNs who are not NPs are known to have been working
in extended roles in remote Australia, little is known about how
they are supported to undertake these roles involving
medications. Further research is warranted to investigate the
legislative models that best facilitate timely access to medicines
in remote Australia and the education and experience that best
prepare RNs to work in extended MMC roles within a quality use
of medicines framework.
Access to essential medicines is a key component of the
National Medicines Policy . A lack of consistency between state
and territory legislative instruments may affect people’s timely
access to medicines in remote Australia and have significant
implications for their health.
Health service delivery involving medicines in remote areas
needs to be consistent across Australia to ensure health
outcomes and health professionals in remote areas are not
unnecessarily compromised. The present situation poses a
considerable risk to the health and rights of many Australians,
particularly those living in very remote areas where the vast
majority of the population is Aboriginal or Torres Strait Islander.
It also poses a considerable risk to the nursing workforce who
may knowingly or not be undertaking aspects of medication
management that are not authorised in their state or territory.
Significant collaborative effort cognisant of models of healthcare
delivery and the needs of people in remote Australia is required
to address the issues identified.
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